Asish K. Xavier
Board Of Director
Pharmaceutical Sciences
 Fusion Pharmaceuticals Inc.
Canada
Biography
Dr. Xavier is with Johnson & Johnson Development Corporation (JJDC) and is based in the Johnson & Johnson Innovation Center in California. Dr. Xavier focuses on venture investments in biotechnology and diagnostics. Dr. Xavier joined JJDC in 2004, and has invested in over a dozen biotech and diagnostics deals. Dr. Xavier previously worked in business development at BioRexis Pharmaceutical Corporation which was acquired by Pfizer in 2007. While at BioRexis, he assisted the company in raising a million second round of financing. Dr. Xavier has worked in business development at Structural GenomiX, Inc., acquired by Eli Lilly in 2008, and was a project leader at Message Pharmaceuticals, Inc. Dr. Xavier received a PhD from the University of Houston in Chemical Engineering, and a MBA from the Wharton School of the University of Pennsylvania, where he graduated with honors. He received a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology, Kanpur, India. Dr. Xavier was a postdoctoral research Fellow in the Department of Chemistry at Johns Hopkins University.
Research Interest
Pharmaceutical Sciences
